Literature DB >> 19326776

In vitro evaluation of hepatic and extra-hepatic metabolism of coumarins using rat subcellular fractions: correlation of in vitro clearance with in vivo data.

Dayanidhi Behera1, Anagha Damre, Alice Varghese, Veeranjaneyulu Addepalli.   

Abstract

7-Ethoxycoumarin (7-EC) and 7-hydroxycoumarin (7-HC) were chosen as model compounds to study hepatic and extra-hepatic metabolism in rat tissue subcellular (microsomal and S9) fractions and to scale the observed in vitro clearance to in vivo plasma clearance. 7-EC and 7-HC showed significant metabolic degradation in liver subcellular fractions as compared to subcellular fractions obtained from intestine, kidney, lung and brain. The total in vitro metabolic clearance for 7-EC and 7-HC was determined by adding the individual in vitro organ clearance values obtained in hepatic and extra-hepatic microsomes or S9 fractions. The predicted in vivo clearance for 7-HC was 63.6 and 81.6 ml/min/kg by in vitro scaling from microsomes and S9 fractions, respectively. For 7-EC, the values were 78.5 and 76.8 ml/min/kg, respectively. The predicted clearance was found to be reasonably accurate with slight over- and underprediction. Interestingly, the relative contribution of hepatic and extra-hepatic metabolism to the total clearance of 7-EC and 7-HC was remarkably high, ranging from 62-77% and 22-38%, respectively, of the total metabolic clearance. It is concluded that the model of multi-organ subcellular fractions is a useful in vitro tool for the prediction of in vivo metabolic clearance, as it can provide information about the relative contribution of extra-hepatic and hepatic metabolism to total metabolic clearance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19326776     DOI: 10.1515/dmdi.2008.23.3-4.329

Source DB:  PubMed          Journal:  Drug Metabol Drug Interact        ISSN: 0792-5077


  4 in total

1.  Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents.

Authors:  Alene T McCoy; Caroline C Benoist; John W Wright; Leen H Kawas; Jyote M Bule-Ghogare; Mingyan Zhu; Suzanne M Appleyard; Gary A Wayman; Joseph W Harding
Journal:  J Pharmacol Exp Ther       Date:  2012-10-10       Impact factor: 4.030

Review 2.  Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models.

Authors:  Sheila Annie Peters; Christopher R Jones; Anna-Lena Ungell; Oliver J D Hatley
Journal:  Clin Pharmacokinet       Date:  2016-06       Impact factor: 6.447

3.  Species-Specific Glucose-6-Phosphatase Activity in the Small Intestine-Studies in Three Different Mammalian Models.

Authors:  Viola Varga; Zsófia Murányi; Anita Kurucz; Paola Marcolongo; Angelo Benedetti; Gábor Bánhegyi; Éva Margittai
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

4.  In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial.

Authors:  Nicoletta Basilico; Silvia Parapini; Anna Sparatore; Sergio Romeo; Paola Misiano; Livia Vivas; Vanessa Yardley; Simon L Croft; Annette Habluetzel; Leonardo Lucantoni; Laurent Renia; Bruce Russell; Rossarin Suwanarusk; Francois Nosten; Giulio Dondio; Chiara Bigogno; Daniela Jabes; Donatella Taramelli
Journal:  Molecules       Date:  2017-12-01       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.